Tranexamic Acid
DrugAdminister 15 mg/kg body weight of tranexamic Acid mixed in 100 mL saline intravenously over 15 min before the skin incision
NCT Number: NCT01027546
The purpose is to evaluate the efficacy of tranexamic acid in cervical laminoplasty; the surgical procedure used was identical in all cases.
Looking for future studies?
Notify MeAll sexes
Interventional
Not applicable
Tranexamic acid, an inhibitor of fibrinolysis, has proven to be effective in reducing perioperative blood loss in patients undergoing total hip and knee arthroplasty. However, limited numbers of well-controlled trials in spinal surgery have been conducted due to heterogeneity in the performed surgical procedures.
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Administer 15 mg/kg body weight of tranexamic Acid mixed in 100 mL saline intravenously over 15 min before the skin incision
Time frame: during and after surgery
Yodakubo Hospital
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03695848
Cervical Myelopathy
Hong Kong
View Trial DetailsNCT02125981
Cervical Myelopathy
Seongnam-si, Gyeonggi-do, South Korea
View Trial DetailsNCT04545983
Bone Diseases, Cervical Myelopathy
Heerlen, Limburg, Netherlands
View Trial DetailsNCT04962256
Cervical Myelopathy
Beijing, Beijing Municipality, China
View Trial Details